tldrdailynews.com logo

Oral Minoxidil Clears Hair-Loss Trial Hurdle, Eyes Regulatory Approval

1 min read
Source: Gizmodo
Oral Minoxidil Clears Hair-Loss Trial Hurdle, Eyes Regulatory Approval
Photo: Gizmodo
TL;DR Summary

Veradermics’ oral minoxidil candidate VDPHL01 posted positive Phase II/III results for mild-to-moderate pattern hair loss, with 79% (single-dose 8.5 mg daily) and 86% (twice-daily) showing significant hair growth versus 36% on placebo, and a safety profile similar to placebo. If approved, it would be the first new oral treatment for pattern baldness in about 30 years, offering a non-hormonal option with an extended-release design to minimize cardiovascular risks.

Topics:business#clinical-trial#hair-loss#health#oral-minoxidil#pattern-baldness#vdphl01
Share this article
  1. ‘Rogaine’ in a Pill? Oral Minoxidil Aces Major Hair Loss Trial  Gizmodo
  2. Veradermics’ hair loss drug succeeds in late-stage trial | STAT  statnews.com
  3. Veradermics soars on positive data for baldness treatment  BioPharma Dive
  4. Veradermics' oral version of hair loss drug succeeds in pivotal study  FirstWord Pharma
  5. Veradermics Shares Jump 17% on Promising Hair Loss Trial Results  Yahoo Finance

Reading Insights

Total Reads

1

Unique Readers

5

Time Saved

3 min

vs 4 min read

Condensed

91%

752 → 68 words

Want the full story? Read the original article

Read on Gizmodo